Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 5
Submit an article Journal homepage
279
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target

Tai-Chung HuangMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Jevon CutlerMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
Shubhada BharneThe Center for Stem Cell Biology and Regenerative Medicine, Department of Pediatrics and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA
,
Jun ZhongMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
,
David WeinstockDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
,
Jeffrey TynerDepartment of Cell and Developmental Biology, Oregon Health and Science University, Portland, OR, USA;Knight Cancer Institute, Portland, OR, USA
,
Ivana GojoJohns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
,
Curt CivinThe Center for Stem Cell Biology and Regenerative Medicine, Department of Pediatrics and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA
&
Akhilesh PandeyMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA;Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USACorrespondence[email protected]
 show all
Pages 1524-1527 | Received 13 May 2014, Accepted 31 Aug 2014, Published online: 05 Nov 2014

References

  • Ensor HM, Schwab C, Russell LJ, et al. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial. Blood 2011;117:2129–2136.
  • Moorman AV, Schwab C, Ensor HM, et al. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia. J Clin Oncol 2012;30:3100–3108.
  • Chen I-M, Harvey RC, Mullighan CG, et al. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study. Blood 2012;119:3512–3522.
  • Mullighan CG, Collins-Underwood JR, Phillips LAA, et al. Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet 2009;41:1243–1246.
  • Russell LJ, Capasso M, Vater I, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood 2009;114:2688–2698.
  • Chapiro E, Russell L, Lainey E, et al. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia 2010;24:642–645.
  • Yoda A, Yoda Y, Chiaretti S, et al. Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia. Proc Natl Acad Sci 2010;107:252–257.
  • van Bodegom D, Zhong J, Kopp N, et al. Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2. Blood 2012;120:2853–2863.
  • Tyner JW, Yang WF, Bankhead A, et al. Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res 2013;73:285–296.
  • Jang Y-J, Ma S, Terada Y, et al. Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian Polo-like kinase. J Biol Chem 2002;277:44115–44120.
  • Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol 2009;10:265–275.
  • Yamashiro S, Yamakita Y, Totsukawa G, et al. Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing Polo-like kinase 1. Dev Cell 2008;14:787–797.
  • Birukova AA, Smurova K, Birukov KG, et al. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 2004;201:55–70.
  • Campana D, Manabe A, Evans WE. Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs. Leukemia 1993;7:482–488.
  • Mihara K, Imai C, Coustan-Smith E, et al. Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase. Br J Haematol 2003;120:846–849.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.